157 related articles for article (PubMed ID: 22626650)
21. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.
Peleg-Raibstein D; Pezze MA; Ferger B; Zhang WN; Murphy CA; Feldon J; Bast T
Neuroscience; 2005; 132(1):219-32. PubMed ID: 15780480
[TBL] [Abstract][Full Text] [Related]
22. Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease.
Liu ZB; Song NN; Geng WY; Jin WZ; Li L; Cao YX; Qian Y; Zhu DN; Shen LL
Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):963-8. PubMed ID: 20528981
[TBL] [Abstract][Full Text] [Related]
23. Orexin and neuropeptide Y: tissue specific expression and immunoreactivity in the hypothalamus and preoptic area of the cichlid fish Cichlasoma dimerus.
Pérez Sirkin DI; Suzuki H; Cánepa MM; Vissio PG
Tissue Cell; 2013 Dec; 45(6):452-9. PubMed ID: 24138942
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of cortical acetylcholine release by orexin A.
Fadel J; Pasumarthi R; Reznikov LR
Neuroscience; 2005; 130(2):541-7. PubMed ID: 15664710
[TBL] [Abstract][Full Text] [Related]
25. [Possible mechanisms for orexin effects on the functioning of the hippocampus and spatial learning (analytical review)].
Sil'kis IG
Zh Vyssh Nerv Deiat Im I P Pavlova; 2012; 62(4):389-400. PubMed ID: 23035556
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice.
Tanaka K; Furuyashiki T; Kitaoka S; Senzai Y; Imoto Y; Segi-Nishida E; Deguchi Y; Breyer RM; Breyer MD; Narumiya S
J Neurosci; 2012 Mar; 32(12):4319-29. PubMed ID: 22442093
[TBL] [Abstract][Full Text] [Related]
27. Ultrastructural localization of Leu5-enkephalin immunoreactivity in mesocortical neurons and their input terminals in rat ventral tegmental area.
Garzón M; Pickel VM
Synapse; 2004 Apr; 52(1):38-52. PubMed ID: 14755631
[TBL] [Abstract][Full Text] [Related]
28. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress.
Baldo BA; Daniel RA; Berridge CW; Kelley AE
J Comp Neurol; 2003 Sep; 464(2):220-37. PubMed ID: 12898614
[TBL] [Abstract][Full Text] [Related]
29. Retrograde study of hypocretin-1 (orexin-A) projections to subdivisions of the dorsal raphe nucleus in the rat.
Lee HS; Park SH; Song WC; Waterhouse BD
Brain Res; 2005 Oct; 1059(1):35-45. PubMed ID: 16153616
[TBL] [Abstract][Full Text] [Related]
30. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression.
Allard JS; Tizabi Y; Shaffery JP; Trouth CO; Manaye K
Neuropeptides; 2004 Oct; 38(5):311-5. PubMed ID: 15464197
[TBL] [Abstract][Full Text] [Related]
31. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.
Ossowska K; Smiałowska M; Kuter K; Wierońska J; Zieba B; Wardas J; Nowak P; Dabrowska J; Bortel A; Biedka I; Schulze G; Rommelspacher H
Neuroscience; 2006 Sep; 141(4):2155-65. PubMed ID: 16797138
[TBL] [Abstract][Full Text] [Related]
32. Strain differences in the distribution of dopamine (DA-2 and DA-3) receptor sites in rat brain.
Yaroslavsky I; Colletti M; Jiao X; Tejani-Butt S
Life Sci; 2006 Jul; 79(8):772-6. PubMed ID: 16574158
[TBL] [Abstract][Full Text] [Related]
33. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2.
Rosin DL; Weston MC; Sevigny CP; Stornetta RL; Guyenet PG
J Comp Neurol; 2003 Oct; 465(4):593-603. PubMed ID: 12975818
[TBL] [Abstract][Full Text] [Related]
34. The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain.
Westerink BH; Enrico P; Feimann J; De Vries JB
J Pharmacol Exp Ther; 1998 Apr; 285(1):143-54. PubMed ID: 9536004
[TBL] [Abstract][Full Text] [Related]
35. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression.
Nollet M; Gaillard P; Minier F; Tanti A; Belzung C; Leman S
Neuropharmacology; 2011; 61(1-2):336-46. PubMed ID: 21530551
[TBL] [Abstract][Full Text] [Related]
36. Dynamic interactions between orexin and dynorphin may delay onset of functional orexin effects: a modeling study.
Williams KS; Behn CG
J Biol Rhythms; 2011 Apr; 26(2):171-81. PubMed ID: 21454297
[TBL] [Abstract][Full Text] [Related]
37. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
Linnér L; Endersz H; Ohman D; Bengtsson F; Schalling M; Svensson TH
J Pharmacol Exp Ther; 2001 May; 297(2):540-6. PubMed ID: 11303041
[TBL] [Abstract][Full Text] [Related]
38. Mu-opioid receptors in the ventral tegmental area are targeted to presynaptically and directly modulate mesocortical projection neurons.
Svingos AL; Garzón M; Colago EE; Pickel VM
Synapse; 2001 Sep; 41(3):221-9. PubMed ID: 11418935
[TBL] [Abstract][Full Text] [Related]
39. Effects of sex and reproductive experience on the number of orexin A-immunoreactive cells in the prairie vole brain.
Donlin M; Cavanaugh BL; Spagnuolo OS; Yan L; Lonstein JS
Peptides; 2014 Jul; 57():122-8. PubMed ID: 24874707
[TBL] [Abstract][Full Text] [Related]
40. [Expression of orexin A, orexin receptor-1, and Ob-R of hypothalamus in rats with chronic renal failure].
Li JL; Zheng FL; Tan HB; Li Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):56-61. PubMed ID: 15052776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
